These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1279607)

  • 41. Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies.
    Franz MR; Swerdlow CD; Liem LB; Schaefer J
    J Clin Invest; 1988 Sep; 82(3):972-9. PubMed ID: 3417875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.
    Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M
    J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does sotalol have reverse-use dependence during tachyarrhythmias?
    Kovoor P; Byth K; Uther JB; Ross DL
    Am J Cardiol; 1996 Jul; 78(2):247-50. PubMed ID: 8712156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prolongation of the human cardiac monophasic action potential by sotalol.
    Echt DS; Berte LE; Clusin WT; Samuelsson RG; Harrison DC; Mason JW
    Am J Cardiol; 1982 Nov; 50(5):1082-6. PubMed ID: 6127944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased dispersion of repolarization time determined by monophasic action potentials in two patients with familial idiopathic ventricular fibrillation.
    Matsuo K; Shimizu W; Kurita T; Suyama K; Aihara N; Kamakura S; Shimomura K
    J Cardiovasc Electrophysiol; 1998 Jan; 9(1):74-83. PubMed ID: 9475580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discrepant effects of mexiletine on cycle length of ventricular tachycardia and on the effective refractory period in the area of slow conduction.
    Aizawa Y; Chinushi M; Kitazawa H; Washizuka T; Abe A; Shibata A; Kodama I
    Heart; 1996 Mar; 75(3):281-6. PubMed ID: 8800993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of termination of supraventricular tachycardias by intravenous class III antiarrhythmic agents. A comparison of amiodarone and sotalol.
    Waleffe A; Nzayinambaho K; Rodriguez LM; Dehareng A; Kulbertus HE
    Eur Heart J; 1989 Dec; 10(12):1084-9. PubMed ID: 2606117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G; Sen L; Sager P; Uppal P; Singh BN
    Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [QT time and the ventricular refractory period in programmed electrical stimulation of the heart in patients with ventricular and supraventricular tachycardias--effect of sotalol].
    Wehr M
    Z Kardiol; 1986 Dec; 75(12):744-50. PubMed ID: 3825224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of standard and high-dose regimens for the initiation of amiodarone therapy.
    Summitt J; Morady F; Kadish A
    Am Heart J; 1992 Aug; 124(2):366-73. PubMed ID: 1636580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
    Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
    Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
    Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS
    J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of benefit of very short basic drive train cycle length or repetition of extrastimulus coupling intervals for induction of ventricular tachycardia.
    Lee CS; Wan SH; Cooper MJ; Ross DL
    J Cardiovasc Electrophysiol; 1998 Jun; 9(6):574-81. PubMed ID: 9654221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sotalol exhibits reverse use-dependent action on monophasic action potentials in normal but not in infarcted canine ventricular myocardium.
    Schmitt C; Beyer T; Karch M; Montero M; Hilbel T; Brachmann J; Kübler W
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):487-92. PubMed ID: 1380589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Correction of rate and structure of ventricular rhythm in permanent atrial fibrillation: a novel pathogenetic approach].
    Nedostup AV; Blagova OV; Bogdanova EA; Platonova AA
    Kardiologiia; 2004; 44(1):31-8. PubMed ID: 15029146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS; Pierangeli A
    Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sympathetic modulation of the relation between ventricular repolarization and cycle length.
    Zaza A; Malfatto G; Schwartz PJ
    Circ Res; 1991 May; 68(5):1191-203. PubMed ID: 2018986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delayed ventricular repolarization as an anti-arrhythmic principle.
    Vaughan Williams EM
    Eur Heart J; 1985 Nov; 6 Suppl D():145-9. PubMed ID: 2417849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.